Internal Medicine · Denver, CO
NPI
1972688554
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
4545 E 9th Ave, Suite 400
Denver, CO, 80220
Phone (303) 320-2929
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$968K
6,219 prescriptions
Company payments, 2025
$1,144
From 19 companies
Medicare prescription drug claims, 2024
In 2024, the drug David L Mellman prescribed most often to Medicare patients was Rosuvastatin Calcium, with 514 prescriptions and refills. In total David L Mellman wrote 6,219 Medicare prescriptions that cost $968K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-21.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Rosuvastatin Calcium Generic | 514 | 1,494 | 172 | $7,251 |
| Atorvastatin Calcium Generic | 327 | 966 | 103 | $3,011 |
| Amlodipine Besylate Generic | 199 | 576 | 67 | $1,701 |
| Levothyroxine Sodium Generic | 187 | 529 | 59 | $2,335 |
| Zolpidem Tartrate Generic | 168 | 206 | 43 | $1,282 |
| Eliquis Apixaban | 160 | 269 | 38 | $154K |
| Valsartan Generic | 131 | 361 | 48 | $2,958 |
| Pantoprazole Sodium Generic | 107 | 291 | 31 | $1,925 |
| Ezetimibe Generic | 105 | 310 | 32 | $2,884 |
| Olmesartan Medoxomil Generic | 104 | 277 | 29 | $2,226 |
| Mounjaro Tirzepatide | 82 | 96 | 14 | $91K |
| Belsomra Suvorexant | 80 | 80 | 21 | $35K |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 79 | 170 | 27 | $9,561 |
| Lisinopril Generic | 73 | 213 | 24 | $499 |
| Tamsulosin Hcl Generic | 72 | 214 | 26 | $1,521 |
Brand drugs: 1,297 claims; generic drugs: 4,903 claims; opioid claims: 103.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David L Mellman $1,144 ($1,144 in general payments such as food, travel and fees) from 19 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $198.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 11 | $198 |
| Lilly USA, LLC LLY | 7 | $155 |
| Abbvie Inc. ABBV | 4 | $97.4 |
| Amgen Inc. AMGN | 5 | $93.56 |
| GlaxoSmithKline, LLC. GSK | 3 | $76.83 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $61.76 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $60.26 |
| Eisai Inc. 4523.T | 3 | $59.36 |
| Novo Nordisk Inc NVO | 3 | $55.84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $52.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.